Top Markets
#1 Black Phoenix Black Phoenix +355.52%
#2 Glidr Glidr +84.34%
#3 Gold Park Gold Park +55.17%
#4 Akedo Akedo +48.78%
#5 Acurast Acurast +29.95%
#6 BasedHype BasedHype +23.54%
#7 Cryptopia Cryptopia +21.54%
#8 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +21.11%
#9 Avantis Avantis +20.16%
#10 Quantum Resistant Ledger Quantum Resistant Ledger +15.50%
Coin of the day
Black Phoenix Black Phoenix
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Histogen Inc. Histogen Inc.

Histogen Inc.

HSTO
Classificação em ações #40868
Histogen Inc. operates as a clinical-stage biotechnology company, focusing on... Histogen Inc. operates as a clinical-stage biotechnology company, focusing on the development of novel, stem cell-free biologic products derived from its proprietary hypoxia-generated growth factor technology platform. Among its offerings is HST-003, a human extracellular matrix, currently undergoing Phase 1/2 clinical trials to mend articular cartilage defects in the knee. Additionally, the company is advancing HST-004, a cell-conditioned media solution designed for spinal disc repair, and Emricasan, an orally active pan-caspase inhibitor targeting COVID-19 treatment. In its preclinical pipeline, Histogen is developing CTS-2090 and CTS-2096. These are selective caspase-1 inhibitors formulated to suppress inflammasome activation and intervene in a range of inflammation-mediated conditions. Founded in 2007, Histogen Inc. maintains its headquarters in San Diego, California.
Preço da ação
$0.02765
Última sincronização: 2024-12-23
Valor de mercado
$69.04K
Variação (1 dia)
0.00%
Variação (1 ano)
0.00%
País
US
Negociar Histogen Inc. (HSTO)

Categoria

Healthcare
Receita da Histogen Inc. (HSTO)
Receita em Sep 2023 TTM: $19.00K
De acordo com os últimos relatórios financeiros da Histogen Inc., a receita atual da empresa (TTM) é $19.00K. Em 2021, a empresa obteve uma receita de $919.00K uma diminuição em relação a a receita do ano 2020, que foi de $2.06M. A receita é o valor total gerado pela venda de bens ou serviços. Ao contrário do lucro, nenhuma despesa é subtraída.
Histórico de receita da Histogen Inc. de 2011 a 2026
Receita no final de cada ano
Ano Receita Alterar
2026 (TTM) $19.00K -99.50%
2022 $3.77M 310.12%
2021 $919.00K -55.37%
2020 $2.06M -82.02%
2019 $11.45M -65.90%
2018 $33.59M -5.06%
2017 $35.38M 4,327.40%
2016 $799.05K 0.00%
2015 0.00 0.00%
2014 0.00 0.00%
2013 0.00 0.00%
2012 0.00 0.00%
2011 0.00 0.00%
Receita de empresas similares ou concorrentes
Empresa Receita Diferença de Receita País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B 66,443,584.21%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B 31,690,885.84%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $10.11B 53,214,566.82%
BE